The Growing Incidence of Chronic Diseases and Urinary Incontinence Drives the Global Pelvic Floor Electric Stimulator Market

According to Ameco Research, the global pelvic floor electric stimulator market size is expected to grow a CAGR above 10% over the projected timeframe and reach a market value of around USD 500 million by 2030.

Over the last few decades, technological developments, in conjunction with research and development programs, have had a significant impact on the healthcare industry. In the healthcare industry, a slew of inventive cutting-edge electrical equipment has entered the market to treat many different types of medical conditions and diseases. Electrical devices, such as pelvic floor electrical stimulation devices, have grown in popularity in recent years as a result of increased public awareness and the emergence of the Internet, especially in regions with a high prevalence of urinary incontinence.

Download Sample Pages Of this report –

The pelvic floor electric stimulator helps to stimulate the pelvic floor muscles with neuromuscular electrical stimulation. It is typically administered using anal or vaginal probes linked to an outward pulse generator. Pelvic floor electrical stimulation devices are a relatively new long-term medical solution for ways to strengthen relatively weak pelvic floor muscles, and they have the potential to be used to minimize the impact of sexual dysfunction, neurodegenerative disease, and urinary incontinence in women and the elderly. In the long run, raising healthcare industry investments in science and innovation of intra-anal or intra-vaginal pelvic electric-powered stimulators are expected to drive market growth for these devices.

Global Pelvic Floor Electric Stimulator Market Growth Aspects

Increased occurrence of neurodegenerative disorders, an aging population, a growing preference for home healthcare, and increased utilization of remote health monitoring in different treatments are expected to drive market growth further. The increased prevalence of urinary incontinence, growing awareness initiatives by various government and private organizations, and rising technological breakthroughs are the most significant growth drivers for this market. The rapid increase in the aging population, which is at a higher risk of urinary incontinence, is one of the primary reasons for the increased consumption of pelvic floor electric stimulators. This device should be used by patients suffering from urologic disorders such as benign prostatic hyperplasia, cystitis, urinary retention, and kidney stones. Doctors generally recommend this product to people who have urinary tract infections.

Similarly, the rising prevalence of hypertension, diabetes and high blood pressure all contribute to an increase in the number of individuals suffering from premature ejaculation. As a result, there is a significant opportunity for pelvic floor electric stimulators. In the near future, female stress urinary incontinence methodology devices will be on the growing market. According to a 2019 World Health Organization report, approximately 1.13 billion people have hypertension. Diabetes is a major cause of advanced renal failure, followed by hypertension, which holds approximately one billion people around the world. Besides that, technological advancements in the healthcare industry, as well as a growing emphasis on non-invasive treatment options, will catalyze increased market share in the coming few years.

Regional Overview                                                                          

North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are the regional classification of the global pelvic floor electric stimulator market. The North America region led the global market in 2021, accounting for a sizable revenue share. Factors such as an aging population, an increase in the prevalence of neurodegenerative diseases, an increase in the prevalence of premature ejaculation, and the presence of major market players in the region can all have an impact on this influence. Furthermore, in terms of innovative technology and facilities, this region is one of the most advanced in the world, resulting in massive health centers and clinical management. A rise in the incidence of chronic health conditions such as sexual problems and neurodegenerative diseases such as Alzheimer’s and Parkinson’s also helps the market. The United States controls more than three-quarters of the North American pelvic floor stimulator market. According to the US Department of Health and Human Services, urinary incontinence affects twice as many women as men. Pregnancy, childbirth, and menopause all contribute to this. Urinary incontinence is not a normal part of aging, and it can be treated. Over the last decade, electrical stimulation has suddenly appeared as one of the most sophisticated and distinguishable types of biofeedback available in the United States for pelvic floor muscle restoration.

Market Segmentation        

The global pelvic floor electric stimulator market segmentation by Ameco Research based on product type, application, and end-users. Based on the product type, the market is divided into fixed, and mobile. Based on the application, the market separated into urinary incontinence, sexual dysfunction, and neurodegenerative diseases. Based on end-users, the market is categorized hospitals & clinics, home care settings, ambulatory surgical units, and others.

Major Players

Some key players covered global in the pelvic floor electric stimulator industry are ActivLife Technologies, Renovia Inc., Verity Medical Ltd., Athena Feminine Technologies, The Prometheus Group, Atlantic Therapeutics, TensCare Ltd., InControl Medical, Laborie Inc., and Zynex Inc.

Buy this premium research report –

Would like to place an order or any question, please feel free to contact at  &

Contact No: + 1 407 915 4157

Leave a Reply

Your email address will not be published. Required fields are marked *